Skip to main content

H.R. 5568

Referred to Committee

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

Introduced 4/18/2018•115th Congress•House

Latest Action

Referred to the House Committee on Energy and Commerce.

4/18/2018 • House

Summary

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)

Introduced in House • 4/18/2018

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Advanced technology and technological innovationsCongressional oversightDrug safety, medical device, and laboratory regulationEducational facilities and institutionsGovernment information and archivesHealth programs administration and fundingHealth technology, devices, suppliesHigher educationManufacturingPrescription drugsProduct development and innovationResearch administration and fundingResearch and development

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Pallone, Frank, Jr. [D-NJ-6]

Democrat • NJ-6

Sponsored 4/18/2018

Cosponsors (1)

R[
Rep. Guthrie, Brett [R-KY-2]

R-KY-2

Joined 4/18/2018

Bill Journey

Originated in the House

Introduced

April 18, 2018

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House4/18/2018

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors1